FLT3 GENE MUTATION

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting FLT3 GENE MUTATION:

# Drug Count
0 AZACITIDINE 13
1 VENETOCLAX 13
2 AZACITIDINE FOR 12
3 VORICONAZOLE 2
4 VORICONAZOLE INJECTION 2
5 FILGRASTIM 1
6 HYDROXYUREA 1
7 OLUTASIDENIB 1
8 POSACONAZOLE 1
9 POSACONAZOLE DELAYED-RELEASE 1
See all common drugs associated with FLT3 GENE MUTATION

FLT3 GENE MUTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OLUTASIDENIB 1 0.0035
1 QUIZARTINIB 1 0.0014
2 AZACITIDINE 13 0.0004
3 VENETOCLAX 13 0.0002
4 VORICONAZOLE 2 0.0001
5 POSACONAZOLE 1 0.0001
6 HYDROXYUREA 1 0.0000
7 FILGRASTIM 1 0.0000
See all drugs enriched for association with FLT3 GENE MUTATION

These drug classes are most commonly taken by patients reporting FLT3 GENE MUTATION:

# Drug class Count
0 BCL-2 Inhibitor [EPC] 13
1 Nucleoside Metabolic Inhibitor [EPC] 13
2 Azole Antifungal [EPC] 3
3 Antimetabolite [EPC] 1
4 Leukocyte Growth Factor [EPC] 1
See all common drug classes associated with FLT3 GENE MUTATION

FLT3 GENE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 13 0.0002
1 Nucleoside Metabolic Inhibitor [EPC] 13 0.0000
2 Azole Antifungal [EPC] 3 0.0000
3 Leukocyte Growth Factor [EPC] 1 0.0000
See all drug classes enriched for association with FLT3 GENE MUTATION